Clinical Efficacy of Megadose Vitamin C in Sepsis - Trial NCT05194189
Access comprehensive clinical trial information for NCT05194189 through Pure Global AI's free database. This Phase 2 trial is sponsored by Zhujiang Hospital and is currently Recruiting. The study focuses on Sepsis,Septic Shock. Target enrollment is 152 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Zhujiang Hospital
Timeline & Enrollment
Phase 2
Feb 08, 2022
Jan 04, 2024
Primary Outcome
28-day all-cause mortality
Summary
In this multicenter, randomized, single-blind, placebo-controlled clinical trial. Patients
 will be randomly assigned to receive Vitamin C or placebo for 4 days or until ICU discharge
 (whatever come first). The primary outcome is 28-day all-cause mortality.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05194189
Non-Device Trial